Cargando…
Mistletoe Extract Viscum Fraxini-2 for Treatment of Advanced Hepatocellular Carcinoma: A Case Series
BACKGROUND: Hepatocellular carcinoma (HCC) is the fourth leading cause of death from cancer worldwide, and for advanced HCC the prognosis is poor. Preliminary studies indicate mistletoe extracts may have anticancer activity for HCC. METHODS: A prospective observational case series of advanced HCC pa...
Autores principales: | Lee, Richard T., Yang, Peiying, Alahmadi, Asrar, McQuade, Jennifer, Yuan, Eric, Difeo, Analisa, Narla, Goutham, Kaseb, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983630/ https://www.ncbi.nlm.nih.gov/pubmed/33776708 http://dx.doi.org/10.1159/000511566 |
Ejemplares similares
-
Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression
por: Yang, Peiying, et al.
Publicado: (2019) -
Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma
por: Mabed, M, et al.
Publicado: (2004) -
Mistletoe preparation (Viscum Fraxini-2) as palliative treatment for malignant pleural effusion: a feasibility study with comparison to bleomycin
por: Gaafar, Rabab, et al.
Publicado: (2014) -
The photosynthesis apparatus of European mistletoe (Viscum album)
por: Schröder, Lucie, et al.
Publicado: (2022) -
Massive gene loss in mistletoe (Viscum, Viscaceae) mitochondria
por: Petersen, G., et al.
Publicado: (2015)